Clinical Trial: CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07659678) titled 'CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma' on June 15.

Brief Summary: This is a prospective study to evaluate the sensitivity and specificity of Cu-64 DOTA-ECL1i PET/CT imaging to serve as a novel precision imaging tool for patients with head and neck squamous cell carcinoma (HNSCC).

Study Start Date: Aug. 31

Study Type: INTERVENTIONAL

Condition: Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma HNSCC

Intervention: DRUG: 64Cu-DOTA-ECL1i

64Cu-DOTA-ECL1i a novel PET imaging tracer that will be provided intravenously...